Answers are grounded in this paper and cite their sources.
Background Whether SARS-CoV-2 infection is a risk factor for splanchnic vein thrombosis (SVT) is unknown. Aim To assess the impact of SARS-CoV-2 infection on the presentation and prognosis of recent SVT and to identify specific characteristics of SARS-CoV-2-associated SVT. Methods : Retrospective study collecting health-related data of 27 patients presenting with recent SVT in the context of SARS-CoV-2 infection in 12 VALDIG centers and comparison to 494 patients with recent SVT before the SARS-CoV-2 pandemic. Results Twenty-one SARS-CoV-2 patients had portal vein thrombosis with or without thrombosis of another splanchnic vein, two had superior mesenteric vein thrombosis, one had splenic vein thrombosis, and three had hepatic vein thrombosis. Diagnosis of SVT was made 10 days (95%CI: 0-24) after the diagnosis of SARS-CoV-2 infection. Fever (52% vs. 15%, p<0.001) and respiratory symptoms (44% vs. 0%, p<0.001) were more frequent, and median lymphocyte count was lower (1.1 10 3 /mm 3 vs. 1.6 10 3 /mm 3 , p=0.043) in patients with infection compared to those without SARS-CoV-2 infection. A prothrombotic condition was identified in 44% and 52% in patients with and without SARS-CoV-2 infection, respectively (p=0.5). All SARS-CoV-2 patients received anticoagulation therapy. During a median follow-up of 250 days, three SARS-CoV-2-infected patients (11%) required intestinal resection for infarction 1 to 3 months after diagnosis of SVT compared to 13 (2.6%) controls (p=0.044). Partial or complete recanalization of the thrombosed splanchnic vein was performed in 33% of SARS-CoV-2 patients. Conclusions SARS-CoV-2 infection can be associated with recent SVT. Intestinal infarction leading to intestinal resection might be more frequent in SARS-CoV-2 patients.
No takes yet. Share an insight, caveat, or question.
Deltenre et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: